Adherence problems in psychiatry arise due to illness-related restrictions, side effects and psychosocial, economic and cultural burdens. Low insight into the illness, affective instability and cognitive deficits make adherence to treatment even more difficult. Structured, individually tailored treatment, modern pharmacotherapy and participatory decision-making can improve adherence in the long term.
Autoren
- Dr. Ulf Blanke
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D
SGLT2i, metformin, or both?
- Biophilic Design of Work Environments
Effects on Health, Well-Being, and Productivity
- From symptom to diagnosis